These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2517950)

  • 1. Generation of syngeneic anti-tumour double negative cells (CD4- CD8-), with cytotoxic activity against clones of different MHC class I expression.
    Caballero A; Garrido A; Algarra I; Perez M; Garrido F
    J Immunogenet; 1989; 16(4-5):321-8. PubMed ID: 2517950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a CD4(L3T4)-positive cytotoxic T cell clone that is restricted by class I major histocompatibility complex antigen on FBL-3 tumor cell.
    Matsubayashi Y; Zenita K; Morioka A; Iwashiro M; Masuda T; Uchino H; Fujita T; Kuribayashi K
    Immunobiology; 1989 Nov; 180(1):33-46. PubMed ID: 2483152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.
    Apasov S; Sitkovsky M
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2837-41. PubMed ID: 8464897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S; Komita H; Sagawa Y; Ohno T; Toda G
    Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes.
    Glas R; Franksson L; Ohlén C; Höglund P; Koller B; Ljunggren HG; Kärre K
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11381-5. PubMed ID: 1454824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).
    Wang P; Vánky F; Klein E
    Int J Cancer; 1992 Jul; 51(6):962-7. PubMed ID: 1386348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
    Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
    Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity.
    Suzuki H; Ikemoto M; Yokoyama A; Kamitani T; Yamashita N; Maruyama M; Yano S
    Cell Immunol; 1991 Jan; 132(1):127-39. PubMed ID: 1829651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rejection of allogeneic tumor is not determined by host responses to MHC class I molecules and is mediated by CD4-CD8+ T lymphocytes that are not lytic for the tumor.
    Cole GA; Ostrand-Rosenberg S
    Cell Immunol; 1991 May; 134(2):480-90. PubMed ID: 1902400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
    Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
    J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of streptococcal antigen-specific CD8+, MHC class I-restricted, T cell clones that down-regulate in vitro antibody synthesis.
    Walker PR; Fellowes R; Hecht EM; Lehner T
    J Immunol; 1991 Nov; 147(10):3370-80. PubMed ID: 1834737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and antigen specificity of CD8+ cytotoxic T lymphocytes in beta 2-microglobulin-negative, MHC class I-deficient mice in response to immunization with tumor cells.
    Apasov SG; Sitkovsky MV
    J Immunol; 1994 Mar; 152(5):2087-97. PubMed ID: 8133027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells.
    Herrmann T; Maryanski JL; Romero P; Fleischer B; MacDonald HR
    J Immunol; 1990 Feb; 144(4):1181-6. PubMed ID: 1968075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Afferent and efferent pathways in T cell responses to MHC class I+, II-hepatocytes.
    Bumgardner GL; Chen S; Hoffman R; Cahill DC; So SK; Platt J; Bach FH; Ascher NL
    Transplantation; 1989 Jan; 47(1):163-70. PubMed ID: 2521406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. I. The role of L3T4+ T cells in the development of allospecific cytotoxicity in hepatocyte-sponge matrix allografts.
    Bumgardner GL; Chen S; Almond PS; Bach FH; Ascher NL; Matas AJ
    Transplantation; 1992 Apr; 53(4):857-62. PubMed ID: 1566351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.